Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-021855
Filing Date
2020-02-14
Accepted
2020-02-14 16:26:04
Documents
4
Group Members
D. E. SHAW & CO., L.L.C.DAVID E. SHAW

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm207206d19_sc13ga.htm SC 13G/A 61129
2 EXHIBIT 1 tm207206d19_ex1.htm EX-99.1 5774
3 EXHIBIT 2 tm207206d19_ex2.htm EX-99.2 5816
4 EXHIBIT 3 tm207206d19_ex3.htm EX-99.3 7138
  Complete submission text file 0001104659-20-021855.txt   81563
Mailing Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036
Business Address 1166 AVENUE OF THE AMERICAS NINTH FLOOR NEW YORK NY 10036 2124780000
D. E. SHAW & CO, L.P. (Filed by) CIK: 0001009268 (see all company filings)

EIN.: 133695715 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

EIN.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86488 | Film No.: 20620556
SIC: 2834 Pharmaceutical Preparations